Azitra Inc (AZTR) Stock Analysis

Azitra Inc (AZTR) is a publicly traded company in the HEALTHCARE sector. It trades at $0.22, carries a market capitalization of $3.63M. This page summarizes the public market data, fundamentals, and frequently asked questions for AZTR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $0.22
• Market Cap: $3.63M
• EPS: $-0.95
• 52-Week High: $2.40
• 52-Week Low: $0.10

Market Sentiment

Azitra Inc currently has a Neutral sentiment score of 0.03.

About Azitra Inc

Azitra Inc (AZTR) is a pre-clinical biopharmaceutical company headquartered in Branford, Connecticut, specializing in precision dermatology through innovative therapeutic solutions. By harnessing advanced technologies such as engineered proteins and live biotherapeutic products, Azitra aims to create targeted treatments for a range of skin disorders. With a commitment to enhancing patient outcomes in dermatological care, the company is strategically positioned to lead advancements in skin dis...

GNG Research Analysis

GNG Research scores Azitra Inc (AZTR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AZTR.

Frequently Asked Questions

Does AZTR pay dividends?

Azitra Inc (AZTR) does not currently pay a regular dividend.

What is AZTR's market cap?

Azitra Inc (AZTR) has a market capitalization of $3.63M with a current stock price of $0.22.